Main > > >PHARMACOGENETICS.

Direct-to-Consumer Pharmacogenetic Reports
The decision allows 23andMe to report directly to customers, without a prescription, the influence their genetics have on how well they metabolize certain medications
USA Approval Date: 2018. 10.31.
(*) Company: 23andMe Inc.
UpDate: 2020. 01.20.


>PHARMACOGENETICS.'s products
This section has no products